159 related articles for article (PubMed ID: 8853492)
1. Prostate cancer screening with PSA, DRE and TRUS.
Cusan L
Can J Oncol; 1994 Nov; 4 Suppl 1():63-4. PubMed ID: 8853492
[No Abstract] [Full Text] [Related]
2. [Comparison between 2 techniques of screening for prostatic carcinoma. Rectal exploration and transrectal ultrasonography vs. prostate specific antigen].
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Santoni R; Cardini S; Zappa M
Radiol Med; 1994 Oct; 88(4):453-7. PubMed ID: 7527916
[TBL] [Abstract][Full Text] [Related]
3. [Diagnostic accuracy of transrectal ultrasonography for screening of prostatic cancer].
Watanabe M; Saitoh M; Watanabe H
Hinyokika Kiyo; 1996 Oct; 42(10):763-6. PubMed ID: 8951472
[TBL] [Abstract][Full Text] [Related]
4. [The digital rectal exam, prostate-specific antigen and transrectal echography in the diagnosis of prostatic cancer].
Martínez de Hurtado J; Chéchile Toniolo G; Villavicencio Mavrich H
Arch Esp Urol; 1995 Apr; 48(3):247-59. PubMed ID: 7538749
[TBL] [Abstract][Full Text] [Related]
5. Screening decreases prostate cancer death: first analysis of the 1988 Quebec prospective randomized controlled trial.
Labrie F; Candas B; Dupont A; Cusan L; Gomez JL; Suburu RE; Diamond P; Lévesque J; Belanger A
Prostate; 1999 Feb; 38(2):83-91. PubMed ID: 9973093
[TBL] [Abstract][Full Text] [Related]
6. [Screening of prostate carcinoma].
Trinkler FB
Ther Umsch; 1995 Jun; 52(6):393-8. PubMed ID: 7541568
[TBL] [Abstract][Full Text] [Related]
7. Screening for prostate cancer.
Waldman AR; Osborne DM
Oncol Nurs Forum; 1994 Oct; 21(9):1513-7. PubMed ID: 7529409
[TBL] [Abstract][Full Text] [Related]
8. Estimation of total PSA with a supersensitive PSA-assay during neo-adjuvant-chemotherapy of prostate cancer before radical resection of prostate.
Spitz J; Enzmann T; Müller W; Weidenfeld M; Köllermann M
Anticancer Res; 1999; 19(4A):2637-40. PubMed ID: 10470209
[TBL] [Abstract][Full Text] [Related]
9. Optimized strategy for detection of early stage, curable prostate cancer: role of prescreening with prostate-specific antigen.
Labrie F; Dupont A; Suburu R; Cusan L; Gomez JL; Koutsilieris M; Diamond P; Emond J; Lemay M; Candas B
Clin Invest Med; 1993 Dec; 16(6):425-39. PubMed ID: 7516831
[TBL] [Abstract][Full Text] [Related]
10. [Screening test for prostate cancer].
Imai K; Kubota Y; Yamanaka H
Gan To Kagaku Ryoho; 1994 Sep; 21(12):1923-7. PubMed ID: 7522000
[TBL] [Abstract][Full Text] [Related]
11. [Clinico-echographic screening in the early diagnosis of prostatic carcinoma. Preliminary results of a feasibility study of a randomized trial].
Ciatto S; Bonardi R; Mazzotta A; Lombardi C; Zappa M
Radiol Med; 1993 Apr; 85(4):430-3. PubMed ID: 7685921
[TBL] [Abstract][Full Text] [Related]
12. [Current role of echography, of PSA and of PSAD in the diagnosis of prostatic carcinoma].
Pizzoccaro M; Valtorta A; Cappellano F; Sironi D; Catanzaro F
Arch Ital Urol Androl; 1994 Sep; 66(4 Suppl):77-80. PubMed ID: 7534169
[TBL] [Abstract][Full Text] [Related]
13. [Early detection of cancer of the prostate. Pros and cons].
Hoesl CE; Altwein JE
MMW Fortschr Med; 2005 Apr; 147(14):32, 34-6. PubMed ID: 15887681
[TBL] [Abstract][Full Text] [Related]
14. Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.
Andriole GL; Levin DL; Crawford ED; Gelmann EP; Pinsky PF; Chia D; Kramer BS; Reding D; Church TR; Grubb RL; Izmirlian G; Ragard LR; Clapp JD; Prorok PC; Gohagan JK;
J Natl Cancer Inst; 2005 Mar; 97(6):433-8. PubMed ID: 15770007
[TBL] [Abstract][Full Text] [Related]
15. Diagnosis of advanced or noncurable prostate cancer can be practically eliminated by prostate-specific antigen.
Labrie F; Candas B; Cusan L; Gomez JL; Diamond P; Suburu R; Lemay M
Urology; 1996 Feb; 47(2):212-7. PubMed ID: 8607237
[TBL] [Abstract][Full Text] [Related]
16. Cryosurgery of prostate cancer. Use of adjuvant hormonal therapy and temperature monitoring--A one year follow-up.
Lee F; Bahn DK; McHugh TA; Kumar AA; Badalament RA
Anticancer Res; 1997; 17(3A):1511-5. PubMed ID: 9179188
[TBL] [Abstract][Full Text] [Related]
17. Prostate volume and cancer in screening programs.
Standaert B; Alwan A; Nelen V; Denis L
Prostate; 1997 Nov; 33(3):188-94. PubMed ID: 9365547
[TBL] [Abstract][Full Text] [Related]
18. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density.
Men S; Cakar B; Conkbayir I; Hekimoglu B
J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539
[TBL] [Abstract][Full Text] [Related]
19. Is a digital rectal examination necessary in the diagnosis and clinical staging of early prostate cancer?
Philip J; Dutta Roy S; Ballal M; Foster CS; Javlé P
BJU Int; 2005 May; 95(7):969-71. PubMed ID: 15839915
[TBL] [Abstract][Full Text] [Related]
20. Volume-adjusted prostate-specific antigen (PSA) variables in detecting impalpable prostate cancer in men with PSA levels of 2-4 ng/mL: transabdominal measurement makes a significant contribution.
Kobayashi T; Kawahara T; Nishizawa K; Ogura K; Mitsumori K; Ide Y
BJU Int; 2005 Jun; 95(9):1245-8. PubMed ID: 15892809
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
